India, Nov. 19 -- image credit- shutterstock

AstraZeneca India, a science-led biopharmaceutical company, is advancing its commitment to chronic respiratory care by extending its successful Centre of Excellence (CoE) concept. This concept originally developed for severe asthma, to the management of Chronic Obstructive Pulmonary Disease (COPD).

The CoE initiative is extended to AERO (Airway Alliance for Excellence in Respiratory Outcomes) Clinics, have established centres in Delhi, Bangalore, Hyderabad, Kerala, Chennai, Goa, and Mohali. These centres will serve as pivotal hubs for expanding nationwide access to patient education, diagnosis, and advanced treatment pathways.

COPD remains a major global health challenge,ranking as the fourt...